stock options
-
Saxo: Yen intervention will be in vain without hawkish signals from the Bank of Japan
Charu Chanana, strategist at Saxo Capital Markets, said the Bank of Japan has once again proven that it can be more dovish than the most dovish expectations on Wall Street.
-
ResMed rose more than 11% before the market opened, and its 2024 third fiscal quarter results exceeded expectations.
Gelonghui April 26|ResMed (RMD.US), an Australian sleep and breathing equipment manufacturing company, rose 11.22% before the market opened to US$204.
-
TSMC rose more than 1% before the market opened, system-level wafer technology will usher in a major breakthrough
Gelonghui April 26 | TSMC (TSM.US) rose 1.3% to US$138.36 before the market opened.
-
Barclays: The U.S. dollar is expected to benefit from global fund managers’ end-of-month rebalancing buying
Barclays foreign exchange strategists said the dollar is expected to be supported by strong buying interest in the end-of-month rebalancing of global fund managers\’ portfolios for the first time since November.
-
Stocks that will see action today (April 26)
Tata Steel will invest £1.25 billion to build a modern electric arc furnace in Port Talbot and commence closure of the existing heavy-end assets in the following months. A Voluntary Redundancy Aspiration process will be launched across Tata Steel UK from May 15. The move follows seven months of formal and informal national-level discussions with UK trade unions, Tata Steel said in a statement.
-
Market to remain positive despite confused global signals
The beginning of a fresh series (July introduction today at the NSE derivative segment) will see domestic markets opening flat on Monday.
-
Sensex, Nifty rally for 6th day running on firm Asian peers; Tech Mahindra jumps over 12%
Equity benchmark indices climbed in early trade on Friday, extending their rally for the sixth day running, on heavy buying in Tech Mahindra and firm trends in Asian markets.
-
Broker’s call: Equitas SFB (Buy)
Target: ₹111
-
Sanyou Medical: Loss of 2.0958 million yuan in the first quarter of 2024
CSI Intelligent Financial Information Sanyou Medical (688085) disclosed its first quarter report for 2024 on April 26. In the first quarter of 2024, the company achieved total operating income of 86.4293 million yuan, a year-on-year decrease of 46.26%; net profit attributable to the parent company was a loss of 2.0958 million yuan, a profit of 34.6535 million yuan in the same period last year; excluding non-net profit loss of 2.9516 million yuan, a profit in the same period last year 30.6539 million yuan; the net cash flow generated from operating activities was -49.5937 million yuan, compared with 40.0311 million yuan in the same period last year; during the reporting period, Sanyou Medical\’s basic earnings per share was -0.01 yuan, and the weighted average return on net assets was -0.11 %.
-
Hengtian Hailong: Net profit in the first quarter of 2024 was 10.4447 million yuan, a year-on-year increase of 14.06%
CSI Intelligent Financial Information Hengtian Hailong (000677) disclosed its first quarter report for 2024 on April 26. In the first quarter of 2024, the company achieved total operating income of 277 million yuan, a year-on-year increase of 15.59%; net profit attributable to the parent company was 10.4447 million yuan, a year-on-year increase of 14.06%; non-net profit after deducting 9.8088 million yuan, a year-on-year increase of 7.37%; generated from operating activities Net cash flow was 39.4949 million yuan, a year-on-year decrease of 23.52%; during the reporting period, Hengtian Hailong\’s basic earnings per share was 0.0121 yuan, and the weighted average return on net assets was 2.24%.